Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease

Ganguly U, Banerjee A, Chakrabarti SS, Kaur U, Sen O, Cappai R, Chakrabarti S.

Biochem J. 2020 Mar 27;477(6):1109-1122. doi: 10.1042/BCJ20190676.

Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?

Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, Strafella AP, Singleton

Neurology. 2020 Mar 17;94(11):481-494. doi: 10.1212/WNL.0000000000009107. Epub 2020 Feb 26.

Parkinson's disease-associated kinase LRRK2 regulates genes required for cell adhesion, polarization, and chemotaxis in activated murine macrophages

Levy DR, Udgata A, Tourlomousis P, Symmons MF, Hopkins LJ, Bryant CE, Gay NJ.

J Biol Chem. 2020 Feb 28:jbc.RA119.011842. doi: 10.1074/jbc.RA119.011842. Online ahead of print.

Sicca Symptoms in Parkinson's Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life

Prell T, Schaller D, Perner C, Witte OW, Grosskreutz J.

Parkinsons Dis. 2020 Feb 12;2020:2958635. doi: 10.1155/2020/2958635. eCollection 2020.

Ultrasound-responsive neurotrophic factor-loaded microbubble- liposome complex: Preclinical investigation for Parkinson's disease treatment

Lin CY, Lin YC, Huang CY, Wu SR, Chen CM, Liu HL.

J Control Release. 2020 May 10;321:519-528. doi: 10.1016/j.jconrel.2020.02.044. Epub 2020 Feb 27.

Human insulin modulates α-synuclein aggregation via DAF-2/DAF-16 signalling pathway by antagonising DAF-2 receptor in C. elegans model of Parkinson's disease

Haque R, Shamsuzzama, Kumar L, Sharma T, Fatima S, Jadiya P, Siddiqi MI, Nazir A.

Oncotarget. 2020 Feb 11;11(6):634-649. doi: 10.18632/oncotarget.27366. eCollection 2020 Feb 11.

A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan

Lahtinen MJ, Haapaniemi TH, Kauppinen MT, Salokorpi N, Heikkinen ER, Katisko JP.

Acta Neurochir (Wien). 2020 May;162(5):1067-1076. doi: 10.1007/s00701-020-04269-x. Epub 2020 Feb 26.

Cross-Sectional Analysis of Backward, Forward, and Dual Task Gait Kinematics in People With Parkinson Disease With and Without Freezing of Gait

Myers PS, Rawson KS, Harrison EC, Horin AP, Sutter EN, McNeely ME, Earhart GM.

J Appl Biomech. 2020 Feb 27:1-11. doi: 10.1123/jab.2019-0253. Online ahead of print.

Synaptic and cellular plasticity in Parkinson's disease

Chu HY.

Acta Pharmacol Sin. 2020 Apr;41(4):447-452. doi: 10.1038/s41401-020-0371-0. Epub 2020 Feb 28.

CD200 maintains the region-specific phenotype of microglia in the midbrain and its role in Parkinson's disease

Wang L, Gong X, Liu Y, Du T, Zhang Z, Zhang T, Wang X.

Glia. 2020 Sep;68(9):1874-1890. doi: 10.1002/glia.23811. Epub 2020 Feb 29.

Determination of Parkinson Disease Laterality After Deep Brain Stimulation Using 123I FP-CIT SPECT

Park HR, Ha S, Lee DS, Im HJ, Paek SH.

Clin Nucl Med. 2020 Apr;45(4):e178-e184. doi: 10.1097/RLU.0000000000002955.

Subcortical atrophy and perfusion patterns in Parkinson disease and multiple system atrophy

Erro R, Ponticorvo S, Manara R, Barone P, Picillo M, Scannapieco S, Cicarelli G, Squillante M, Volpe G, Esposito F, Pellecchia MT.

Parkinsonism Relat Disord. 2020 Mar;72:49-55. doi: 10.1016/j.parkreldis.2020.02.009. Epub 2020 Feb 21.

In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson's Disease in Common Marmosets

Vermilyea SC, Babinski A, Tran N, To S, Guthrie S, Kluss JH, Schmidt JK, Wiepz GJ, Meyer MG, Murphy ME, Cookson MR, Emborg ME, Golos TG.

Sci Rep. 2020 Feb 26;10(1):3447. doi: 10.1038/s41598-020-60273-2.

Astragalus polysaccharide exerts anti-Parkinson via activating the PI3K/AKT/mTOR pathway to increase cellular autophagy level in vitro

Tan Y, Yin L, Sun Z, Shao S, Chen W, Man X, Du Y, Chen Y.

Int J Biol Macromol. 2020 Jun 15;153:349-356. doi: 10.1016/j.ijbiomac.2020.02.282. Epub 2020 Feb 26.

Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson's disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin

Guo CH, Cao T, Zheng LT, Waddington JL, Zhen XC.

Acta Pharmacol Sin. 2020 Apr;41(4):499-507. doi: 10.1038/s41401-020-0379-5. Epub 2020 Feb 28.